Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma

Cancer Research

Volumn 70, Issue 19, 2010, Pages 7534-7542

  Zhou, Mi ^a   Wiemels, Joseph L ^a   Bracci, Paige M ^a   Wrensch, Margaret R ^a   Mccoy, Lucie S ^a   Rice, Terri ^a   Sison, Jennette D ^a   Patoka, Joseph S ^a   Wiencke, John K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD23 ANTIGEN; DEXAMETHASONE; IMMUNOGLOBULIN E; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETIC ASSOCIATION; GLIOMA; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; DACARBAZINE; DEXAMETHASONE; FEMALE; GLIOMA; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; RECEPTORS, IGE; YOUNG ADULT;

EID: 77957343460     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0815     Document Type: Article

References (41)

1. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009;41:905-8.
2. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41: 899-904.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002;4:278-99.
4. Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106: 423-8.
5. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609-15.
6. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007;99:1544-50.
7. Wiemels JL, Wiencke JK, Patoka J, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004;64:8468-73.
8. Wiemels JL, Wilson D, Patil C, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 2009;125:680-7.
9. Gomariz RP, Gutierrez-Canas I, Arranz A, et al. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics. Curr Pharm Des 2010;16:1063-80.
10. Sumida T. [Mechanism of allergy - innate immunity and acquired immunity]. Nippon Rinsho 2009;67:2030-1.
11. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 2000;18:709-37.
12. Rambert J, Mamani-Matsuda M, Moynet D, et al. Molecular blocking of CD23 supports its role in the pathogenesis of arthritis. PLoS ONE 2009;4:e4834.
13. Massa M, Pignatti P, Oliveri M, De Amici M, De Benedetti F, Martini A. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis. Clin Exp Rheumatol 1998;16:611-6.
14. Lecoanet-Henchoz S, Gauchat JF, Aubry JP, et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995;3: 119-25.
15. Rezzonico R, Imbert V, Chicheportiche R, Dayer JM. Ligation of CD11b and CD11c β(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production in primary human monocytes through a pathway dependent on nuclear factor-κB. Blood 2001;97:2932-40.
16. Aubry JP. CD21 is a ligand for CD23 and regulates IgE production. Nature 1992;358:3.
17. Dugas N, Lacroix C, Kilchherr E, Delfraissy JF, Tardieu M. Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis. Cytokine 2001;15:96-107.
18. Schumann RR. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 1992;143:11-5.
19. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23: 301-4.
20. Arias MA, Rey Nores JE, Vita N, et al. Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 2000;164:3480-6.
21. Vercelli D, Baldini M, Stern D, Lohman IC, Halonen M, Martinez F. CD14: a bridge between innate immunity and adaptive IgE responses. J Endotoxin Res 2001;7:45-8.
22. Zdolsek HA, Jenmalm MC. Reduced levels of soluble CD14 in atopic children. Clin Exp Allergy 2004;34:532-9.
23. Lundell AC, Andersson K, Josefsson E, Steinkasserer A, Rudin A. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation. Infect Immun 2007;75: 4097-104.
24. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002;360:465-6.
25. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{β}-stimulated microglial activation. J Neurosci 2009;29:11982-92.
26. Yin GN, Jeon H, Lee S, Lee HW, Cho JY, Suk K. Role of soluble CD14 in cerebrospinal fluid as a regulator of glial functions. J Neurosci Res 2009;87:2578-90.
27. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001;45:27-36.
28. Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 2004;11:325-9.
29. Szeinbach SL, Barnes JH, Sullivan TJ, Williams PB. Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol 2001;86:373-81.
30. Tada M, de Tribolet N. Immunobiology of malignant gliomas. J Clin Neurosci 1996;3:102-13.
31. Heimberger AB, Sun W, Hussain SF, et al. Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study. Neuro Oncol 2008;10:98-103.
32. Wuthrich B, Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin- 6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992;284:339-42.
33. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-33.
34. Deininger MH, Meyermann R, Schluesener HJ. Expression and release of CD14 in astrocytic brain tumors. Acta Neuropathol 2003;106:271-7.
35. Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 1993;23:2144-51.
36. Rey Nores JE, Bensussan A, Vita N, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265-76.
37. Fu SL, Pierre J, Smith-Norowitz TA, et al. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008;153:401-9.
38. Lachaux A, Kaiserlian D. [CD23: structures, functions and practical perspectives in allergy reactions]. Pediatrie 1993;48:305-12.
39. Bansal AS, Haeney MR, Cochrane S, et al. Serum soluble CD23 in patients with hypogammaglobulinaemia. Clin Exp Immunol 1994;97: 239-41.
40. Garty BZ, Monselise Y, Nitzan M. Soluble CD14 in children with status asthmaticus. Isr Med Assoc J 2000;2:104-7.
41. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;113:1953-68.